fbpx
Thursday, April 25, 2024

New committee to modernise prostheses applications

The Australian Government has today announced it will modernise the existing committee process for prostheses applications through the new Medical Devices and Human Tissue Advisory Committee (MDHTAC).

Like the Prostheses List Advisory Committee it replaces, the new committee will provide recommendations and advice about the comparative clinical effectiveness and cost effectiveness of medical devices and human tissue products on the prostheses list, and the benefits payable by private health insurers.

Minister for Health and Aged Care, Mark Butler said the new committee will help streamline pathways for innovative applications to ensure all Australians have access to medical interventions while supporting the sustainable management of health technologies when funded in the private health system.

“The Government is working to better align private system prices for surgical devices with those paid within the public health system,” Mr Butler said.

“Our priority is to make sure all Australians can access affordable medical devices and the taxpayer gets value for money—in the public and private health systems.

“The Government looks forward to working closely with Professor Campbell and the Medical Devices and Human Tissue Advisory Committee to modernise and streamline how health technologies are used and funded.”

The MDHTAC will also include a larger number of clinical experts to strengthen the advice it provides to the Government, the Minister said.

Emeritus Professor Terry Campbell AM has been appointed Chair of the new committee. Emeritus Professor Campbell is currently the Chair of the Prostheses List Advisory Committee.

Minister Butler said Emeritus Professor Campbell’s appointment will provide continuity to the sector and support prostheses list reforms. The new committee will begin on 1 July 2023 and meet at least three times a year.

The new Committee is expected to include members with expertise in highly technical/specialised surgery and interventional work, health technology, health economic and/or consumer representation and will be supported by six Expert Clinical Advisory Groups. 

Latest Articles